APA (7th ed.) Citation

AL, D., A, M., M, S., S, S., A, C., C, V., . . . M, M. (2024). Effectiveness and safety of cefazolin versus cloxacillin in endocarditis due to methicillin-susceptible Staphylococcus spp: A multicenter propensity weighted cohort study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 43(8), 1569. https://doi.org/10.1007/s10096-024-04851-6

Chicago Style (17th ed.) Citation

AL, Destrem, et al. "Effectiveness and Safety of Cefazolin Versus Cloxacillin in Endocarditis Due to Methicillin-susceptible Staphylococcus Spp: A Multicenter Propensity Weighted Cohort Study." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 43, no. 8 (2024): 1569. https://doi.org/10.1007/s10096-024-04851-6.

MLA (9th ed.) Citation

AL, Destrem, et al. "Effectiveness and Safety of Cefazolin Versus Cloxacillin in Endocarditis Due to Methicillin-susceptible Staphylococcus Spp: A Multicenter Propensity Weighted Cohort Study." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, vol. 43, no. 8, 2024, p. 1569, https://doi.org/10.1007/s10096-024-04851-6.